Proteomics International’s 2021 Annual General Meeting of Shareholders was held on Thursday, 25 Nove...
Proteomics International presented an ePoster at ASN Kidney Week 2021. Over 10,000 nephrologists, ph...
PromarkerD, the only low cost, high speed test capable of predicting the onset of diabetic kidney di...
Proteomics International displayed a virtual booth at the 57th European Association for the Study of...
Proteomics International Laboratories Ltd (Proteomics International; ASX: PIQ) is pleased to release...
Proteomics International will showcase PromarkerD at the Australasian Diabetes Congress, the largest...
Proteomics International showcased PromarkerD at the American Diabetes Association’s 81st Scientific...
Proteomics International will be showcasing PromarkerD at the 58th ERA-EDTA Congress, Europe’s leadi...
Proteomics International attended the Professional Society for Health Economics and Outcomes Researc...
Proteomics International Laboratories Ltd (Proteomics International; ASX: PIQ) is pleased to release...
PromarkerD, the only low cost, high speed test capable of predicting the onset of diabetic kidney di...
PromarkerD, the only low cost, high speed test capable of predicting the onset of diabetic kidney di...
Proteomics International attended the Lorne Proteomics 2021 Virtual symposium. The Company has been ...